GB0329617D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB0329617D0
GB0329617D0 GB0329617A GB0329617A GB0329617D0 GB 0329617 D0 GB0329617 D0 GB 0329617D0 GB 0329617 A GB0329617 A GB 0329617A GB 0329617 A GB0329617 A GB 0329617A GB 0329617 D0 GB0329617 D0 GB 0329617D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0329617A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research
Astex Technology Ltd
Cancer Research Technology Ltd
Original Assignee
Institute of Cancer Research
Astex Technology Ltd
Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research, Astex Technology Ltd, Cancer Research Technology Ltd filed Critical Institute of Cancer Research
Priority to GB0329617A priority Critical patent/GB0329617D0/en
Publication of GB0329617D0 publication Critical patent/GB0329617D0/en
Priority to EP04806258A priority patent/EP1706385B1/en
Priority to EP10168024A priority patent/EP2228369A1/en
Priority to SI200431571T priority patent/SI1706385T1/en
Priority to CN2004800420375A priority patent/CN1922148B/en
Priority to UAA200608166A priority patent/UA90461C2/en
Priority to PL04806258T priority patent/PL1706385T3/en
Priority to CA2548374A priority patent/CA2548374C/en
Priority to AU2004303602A priority patent/AU2004303602C1/en
Priority to KR1020067014742A priority patent/KR101164258B1/en
Priority to JP2006546339A priority patent/JP4928949B2/en
Priority to BRPI0418078A priority patent/BRPI0418078A8/en
Priority to DE602004029501T priority patent/DE602004029501D1/en
Priority to MEP-2010-532A priority patent/ME01934B/en
Priority to RU2006126789/04A priority patent/RU2419612C2/en
Priority to NZ547696A priority patent/NZ547696A/en
Priority to PT04806258T priority patent/PT1706385E/en
Priority to RSP-2010/0532A priority patent/RS51546B/en
Priority to US10/596,788 priority patent/US8247576B2/en
Priority to AT04806258T priority patent/ATE483689T1/en
Priority to DK04806258.2T priority patent/DK1706385T3/en
Priority to MXPA06007326A priority patent/MXPA06007326A/en
Priority to PCT/GB2004/005464 priority patent/WO2005061463A1/en
Priority to UY28946A priority patent/UY28946A1/en
Priority to NO20062633A priority patent/NO20062633L/en
Priority to IL176400A priority patent/IL176400A/en
Priority to ZA200605127A priority patent/ZA200605127B/en
Priority to HK07103603.6A priority patent/HK1097543A1/en
Priority to HR20100675T priority patent/HRP20100675T1/en
Priority to CY20111100002T priority patent/CY1111493T1/en
Priority to US13/536,174 priority patent/US8691806B2/en
Priority to US14/180,440 priority patent/US9283226B2/en
Priority to US15/010,831 priority patent/US20160250187A1/en
Ceased legal-status Critical Current

Links

GB0329617A 2003-12-23 2003-12-23 Pharmaceutical compounds Ceased GB0329617D0 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
GB0329617A GB0329617D0 (en) 2003-12-23 2003-12-23 Pharmaceutical compounds
PCT/GB2004/005464 WO2005061463A1 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
PT04806258T PT1706385E (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
US10/596,788 US8247576B2 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
SI200431571T SI1706385T1 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
RSP-2010/0532A RS51546B (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
UAA200608166A UA90461C2 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
PL04806258T PL1706385T3 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
CA2548374A CA2548374C (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
EP10168024A EP2228369A1 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
KR1020067014742A KR101164258B1 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
JP2006546339A JP4928949B2 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
BRPI0418078A BRPI0418078A8 (en) 2003-12-23 2004-12-23 compound or a salt, solvate, tautomer or n-oxide thereof, use of a compound, methods for the prophylaxis or treatment of an unhealthy protein kinase b-mediated condition and condition to treat a disease or condition for inhibiting a protein kinase b and a protein kinase a, to modulate a cellular process, to treat an immune disorder in a mammal and to induce apoptosis in a cancer cell, pharmaceutical composition, and process for the preparation of a compound.
DE602004029501T DE602004029501D1 (en) 2003-12-23 2004-12-23 PYRAZOL DERIVATIVES AS MODULATORS OF PROTEIN KINASE
MEP-2010-532A ME01934B (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
AT04806258T ATE483689T1 (en) 2003-12-23 2004-12-23 PYRAZOLE DERIVATIVES AS MODULATORS OF PROTEIN KINASE
NZ547696A NZ547696A (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
EP04806258A EP1706385B1 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
CN2004800420375A CN1922148B (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
AU2004303602A AU2004303602C1 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
RU2006126789/04A RU2419612C2 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
DK04806258.2T DK1706385T3 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
MXPA06007326A MXPA06007326A (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators.
UY28946A UY28946A1 (en) 2003-12-23 2005-06-08 ARIL-Y HETEROARIL-ALQUILANINA COMPOUNDS CONTAINING PIRAZOL, PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS AND NEW INTERMEDIATE CHEMICALS
NO20062633A NO20062633L (en) 2003-12-23 2006-06-08 Pyrazole derivatives as protein kinase modulators
IL176400A IL176400A (en) 2003-12-23 2006-06-19 Pyrazole derivatives as protein kinase modulators
ZA200605127A ZA200605127B (en) 2003-12-23 2006-06-21 Pyrazole derivatives as protein kinase modulators
HK07103603.6A HK1097543A1 (en) 2003-12-23 2007-04-03 Pyrazole derivatives as protein kinase modulators
HR20100675T HRP20100675T1 (en) 2003-12-23 2010-12-07 Pyrazole derivatives as protein kinase modulators
CY20111100002T CY1111493T1 (en) 2003-12-23 2011-01-03 PYRAZOLI PRODUCERS AS PROTEIN MODIFICANTS
US13/536,174 US8691806B2 (en) 2003-12-23 2012-06-28 Pyrazole derivatives as protein kinase modulators
US14/180,440 US9283226B2 (en) 2003-12-23 2014-02-14 Pyrazole derivatives as protein kinase modulators
US15/010,831 US20160250187A1 (en) 2003-12-23 2016-01-29 Pyrazole derivatives as protein kinase modulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0329617A GB0329617D0 (en) 2003-12-23 2003-12-23 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB0329617D0 true GB0329617D0 (en) 2004-01-28

Family

ID=30776233

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0329617A Ceased GB0329617D0 (en) 2003-12-23 2003-12-23 Pharmaceutical compounds

Country Status (11)

Country Link
CN (1) CN1922148B (en)
AT (1) ATE483689T1 (en)
DE (1) DE602004029501D1 (en)
DK (1) DK1706385T3 (en)
GB (1) GB0329617D0 (en)
ME (1) ME01934B (en)
PT (1) PT1706385E (en)
RS (1) RS51546B (en)
SI (1) SI1706385T1 (en)
UA (1) UA90461C2 (en)
ZA (1) ZA200605127B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0704932D0 (en) * 2007-03-14 2007-04-25 Astex Therapeutics Ltd Pharmaceutical compounds
CN108339121A (en) * 2017-01-25 2018-07-31 苏州大学 Purposes of the protein kinase A inhibitor in preparing treatment platelet counts and increasing relevant disease drug
CN111056990B (en) * 2019-12-16 2022-06-17 爱斯特（成都）生物制药股份有限公司 Preparation method for synthesizing 1-tert-butyloxycarbonyl-4- (4-carboxyphenyl) piperidine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804734D0 (en) * 1998-03-05 1998-04-29 Pfizer Ltd Compounds
IL147757A0 (en) * 1999-07-30 2002-08-14 Abbott Gmbh & Co Kg 2-pyrazolin-5-ones

Also Published As

Publication number Publication date
DE602004029501D1 (en) 2010-11-18
CN1922148A (en) 2007-02-28
ATE483689T1 (en) 2010-10-15
RS51546B (en) 2011-06-30
UA90461C2 (en) 2010-05-11
PT1706385E (en) 2010-12-22
ME01934B (en) 2011-06-30
ZA200605127B (en) 2010-07-28
CN1922148B (en) 2012-03-21
DK1706385T3 (en) 2011-01-10
SI1706385T1 (en) 2011-01-31

Similar Documents

Publication Publication Date Title
EG27104A (en) Pharmaceutical compounds
GB0315657D0 (en) Pharmaceutical compounds
GB0218625D0 (en) Pharmaceutical compounds
GB0324886D0 (en) Medicinal compounds
GB0303396D0 (en) Medicinal compounds
HU0301154D0 (en) Pharmaceutical composition
GB0300427D0 (en) Pharmaceutical composition
GB0308511D0 (en) Pharmaceutical compounds
GB0215775D0 (en) Pharmaceutical compounds
GB0307866D0 (en) Pharmaceutical composition
EP1699458A4 (en) Pharmaceutical composition
EP1778252A4 (en) Noncardiotoxic pharmaceutical compounds
GB0329232D0 (en) Pharmaceutical composition
GB0317663D0 (en) Pharmaceutical composition
GB0317315D0 (en) Pharmaceutical compounds
GB0328490D0 (en) Medicinal compounds
GB0300885D0 (en) Pharmaceutical composition
GB0313766D0 (en) Pharmaceutical compounds
GB0301736D0 (en) Pharmaceutical compounds
GB2401043B (en) Drug
GB0316889D0 (en) Pharmaceutical agents
GB0306933D0 (en) Pharmaceutical composition
GB0329617D0 (en) Pharmaceutical compounds
GB0307869D0 (en) Pharmaceutical composition
GB0310361D0 (en) Pharmaceutical compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)